Conductive thermal ablation device
Microneedle arrays in thermal ablation devices provide precise tissue destruction by enhancing focality and minimizing damage to healthy tissue, addressing the limitations of existing thermal ablation methods.
Patent Information
- Application Number
- PCT/US2025/028803
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-05-11
- Publication Date
- 2026-11-19
AI Technical Summary
Existing thermal ablation devices lack precision in targeting tissue, often causing incomplete ablation of lesions and damage to surrounding healthy tissue, leading to increased pain, treatment frequency, and complications.
The use of microneedle arrays as thermal conductors for localized tissue destruction, which enhance focality and minimize contact time while reducing complications by precisely controlling thermal energy transfer.
The microneedle arrays allow for more precise localization of tissue destruction, reducing pain and risks of infection and bleeding, while effectively treating both benign and malignant dermal conditions and internal tissue masses.
Smart Images

Figure US2025028803_19112026_PF_FP_ABST
Abstract
Description
HENK_100.100CONDUCTIVE THERMAL ABLATION DEVICEBACKGROUNDTechnical Field
[0001] The disclosures herein relate to temperature-based tissue ablation devices and methods. Specifically, the disclosed invention relates to thermal ablation devices incorporating microneedles that facilitate precise thermal conduction to produce focused tissue treatment or destruction.Background
[0002] Many therapeutic medical interventions involve the use of targeted tissue destruction using some sort of energy source. Examples include electromagnetic or mechanical energy delivered by a device, including radiofrequency energy, focused ultrasound, and others. Direct application of thermal energy to a target tissue is also widely used. Thermal ablation includes both positive and negative energy with respect to body temperature; namely, application of heat (thermal ablation) or freezing (cryotherapy). Thermal therapies are used to treat a variety of conditions, including benign and malignant skin lesions, trans-vaginal applications for treating uterine fibroids, and adenomyosis, and tumors; transurethral applications for treating benign or malignant conditions of the prostate and urinary tract, other trans-luminal applications, and percutaneous entry into solid organs such as the liver or kidney, for example.
[0003] Current thermal ablation devices operate by effecting heat transfer between tissue and a thermal delivery device or medium placed in physical contact with the tissue Such devices utilize a variety of thermal delivery means, including, for example, spray mechanisms, and surface contact with a blunt mechanical tip or an internal needle. During use of the device, heat transfer between the device and target tissue occurs resulting in cell death. In some cases, preservation of the extracellular matrix remaining after thermal ablation promotes the migration of healthy cells into the treated area.
[0004] There are multiple problems associated with this traditional approach. Existing devices do not account for irregular dimensions and other differences in the geometry of a target tissue. Rather, existing devices broadly apply a thermal load to a relatively small, focal area upon the surface or within the center of the target tissue. TheseHENK_100.100methods produce unfavorable results through imprecise thermal delivery with incomplete ablation of the target lesion, thermal damage to adjacent healthy tissue, need for multiple treatments, increased pain, and others. In the field of oncology, it is necessary to kill all of the cancerous or other targeted problematic tissue. At the same time, it is highly desirable to preserve normal, non-cancerous tissue surrounding a tumor.
[0005] The extent of ablated tissue and precise location of the boundary between nonviable and viable tissue is difficult to control with existing devices and methods. Very commonly, treatment results in both incomplete ablation of the target lesion and damage to normal tissue. When ablating a solid mass of tissue, such as a tumor, thermal damage by heat destruction or freezing typically extends into surrounding normal tissue, creating a mantle of injured tissue often well beyond the therapeutic target. The undesired destruction of healthy tissue results in increased inflammation, edema (swelling) and pain. A larger ablated tissue mass also increases risks for bleeding and infection. When topical cryotherapy is used in dermatology for ablation of skin lesions, the procedure can be especially painful, particularly when treating skin lesions on sensitive areas, like the face and hands.
[0006] Consequently, there is a need for thermal ablation devices and methods that delivery thermal energy more precisely to targeted tissue to completely destroy a target lesion while preserving as much surrounding normal tissue as possible. A means of increased control of thermal energy delivery is needed to more effectively treats targeted tissue and reduce unintentional destruction of surrounding, healthy tissue. A precise, focused means for conductive thermal ablation with maximal preservation of healthy surrounding tissue that reduce treatment time, treatment frequency, and patient discomfort, and patient complications is needed.BRIEF SUMMARY
[0007] Disclosed herein are thermal ablation devices and methods engineered to treat target tissue, reduce pain, reduce treatment time and frequency, reduce complications, and promote a more robust healing response by sparing healthy tissue more precisely.
[0008] Microneedles are commonly used in medical applications, including aesthetic therapies, drug delivery, and sample collection. In cosmetics, piercing skin with microneedles creates a mild inflammatory response which activates the immune system , stimulates production of collagen and elastin production to improve skinHENK_100.100appearance. When used in drug delivery applications, coated, hollow, or solid, dissolvable microneedles evenly deliver therapeutic medications while minimizing pain. Modified acupuncture techniques using microneedles are well suited for treating chronic pain conditions, such as back pain and rheumatoid arthritis. Hollow microneedles are used to painlessly collect microliter sample volumes of blood or other fluids for analysis.
[0009] Some embodiments of the devices and methods disclosed herein employ microneedles as thermal conductors for localized tissue destruction. Disclosed devices incorporating a plurality of microneedles maximize focality of tissue destruction and minimize contact time while reducing complications associated with topical or internal cryotherapy through precise control of thermal energy transfer.
[0010] Accordingly, various embodiments of a conductive thermal ablation device and methods of use thereof are disclosed herein. The disclosed devices utilize microneedle having different dimensions arranged in arrays of various configurations. A microneedle array, alone or coupled to an existing thermal delivery device, allows for more precise localization of tissue destruction thereby increasing likelihood of successful treatment while reducing pain and the risks of infection, and bleeding associated with damage to surrounding, healthy tissue.
[0011] The devices and techniques disclosed herein can be used topically in dermatologic applications such as treatment of both benign and malignant dermal conditions. Some examples include skin lesions, warts, skin cancers, and the like. Further, certain embodiments of the disclosed devices and methods can be used to treat internal tissue masses, such as hepatic, renal, and uterine tumors, for example.
[0012] Disclosed herein are embodiments of a thermal ablation device. The thermal ablation device comprises a central body having a first wall and a contact wall; and a plurality of microneedles, each microneedle having a base coupled to the contact wall and a length extending from the base ending in a tip opposite the base.
[0013] In some embodiments, the plurality of microneedles forms a planar array on the contact wall. In some embodiments, the planar array is a two-dimensional shape from the group of shapes consisting of a circle, an ellipse, a triangle, a rectangle, a polygon, or a combination thereof.
[0014] In some embodiments, the contact wall presents a three-dimensional surface from a group of three-dimensional shapes consisting of a sphere, a hemisphere, a cone, a pyramid, a cylinder, a polygonal prism, or a combination thereofHENK_100.100
[0015] In some embodiments, the thermal ablation device further comprises a thermal reservoir thermally coupled to the central body. The thermal reservoir can apply a hot or cold thermal load to the central body and plurality of microneedles.
[0016] In some embodiments, the microneedle length varies across the array to collectively form a curvilinear needle tip array. In some embodiments, the needle tip array forms a hemispherical surface curve. In some embodiments, the needle tip array forms a cylindrical surface curve. In some embodiments, the needle tip array forms a semi -lenticular surface curve.
[0017] In some embodiments, the central body is an inflatable balloon wherein the contact surface is formed by an outer surface of the balloon. The inflatable balloon is provided in a variety of shapes including cylindrical, tapered, stepped, conical, spherical, dog-bone, square, offset, or combination thereof. In some embodiments, the plurality of microneedles coupled to the contact surface are movable between a first (retracted) position and a second (extended) position. In some embodiments, the balloon is coupled to a catheter and configured to be deployed from a distal end of a catheter outer sheath.
[0018] In some embodiments, the thermal ablation device comprises a cooling device from a group of cooling devices consisting of a cryogenic device, or a thermoelectric effect cooling device. In other embodiments, the thermal ablation device comprises a heating device from a group of heating devices consisting of a resistive heating, an induction heating, a radiofrequency heating, a microwave heating, laser ablation, or a thermoelectric effect heating device.
[0019] Disclosed is a thermal ablation device comprising a tip having a central body with a first wall configured to contact a thermal source and a contact wall positioned proximate to a lesion; a plurality of microneedles, each microneedle having a base coupled to the contact wall and a length extending from the base ending in a tip opposite the base; and an attachment means configured to removably couple the central body to a thermal delivery device.
[0020] Disclosed is a method of using a thermal ablation device comprising steps obtaining a thermal ablation device having a central body coupled to a plurality of microneedles; coupling a thermal delivery device configured to deliver a thermal load to the thermal ablation device; contacting a target tissue surface with the thermal ablation device wherein the microneedles penetrate through the tissue surface into the target tissue; activating the thermal delivery device causing a thermal load to beHENK_100.100delivered to the central body for a time period; deactivating the thermal delivery device when the time period is complete; and removing the thermal ablation device from the target tissue surface.
[0021] In some embodiments, the target tissue of the method is a common skin wart, a genital wart, a perianal wart, a seborrheic keratosis, a skin tag, a cherry angioma, a solar lentigo, a lentigo maligna, a solar lentigo, a uterine fibroid, an arteriovenous malformation, an actinic keratosis, a squamous cell carcinoma, a basal cell carcinoma, or a melanoma. These are representative examples and not an all-inclusive list of target tissues.
[0022] In some embodiments, the thermal ablation device is a multi-use device. In some embodiments, the thermal ablation device comprises a three-dimensional microneedle array forming a deep tissue conductive apparatus. In some embodiments, the microneedles are curvilinear.
[0023] In some embodiments, the method further comprises a calculating step wherein the time period is calculated to produce an ablation boundary having a depth, shape, and volume to include the target tissue and exclude a non-target tissue bordering the target tissue. In some embodiments, the method further comprises using data to improve thermal ablation. For example, the data includes pathology, gross images, radiology, and other imaging techniques.
[0024] The foregoing and other features and advantages of the invention will be apparent to those of ordinary skill in the art from the following more particular description of the invention and the accompanying drawings.BRIEF DESCRIPTION OF THE DRAWINGS
[0025] FIG. 1A is an perspective view of a prior art conductive thermal ablation device;
[0026] FIG. IB is an illustration of a prior art cryotherapy device;
[0027] FIG. 2A is an perspective view of a microneedle thermal ablation device;
[0028] FIG. 2B is a side view of a microneedle thermal ablation device;
[0029] FIG. 2C is a partial side view of a microneedle thermal ablation device;
[0030] FIG. 2D is a side view of an alternative embodiment of a microneedle thermal ablation device;
[0031] FIG. 3A a cross-sectional view of a cutaneous wart treated with a prior art thermal ablation device;HENK_100.100
[0032] FIG. 3B is a cross-sectional view of a cutaneous wart treated with the presently disclosed microneedle thermal ablation device;
[0033] FIG. 4A is an perspective view of one embodiment of a microneedle applicator;
[0034] FIG. 4B is a cutaway view of the embodiment of FIG 4A;
[0035] FIG. 5A is an perspective view of another embodiment of a microneedle applicator for treating multiple dermal lesions;
[0036] FIG. 5B is a cutaway view of the embodiment of FIG 5A;
[0037] FIG. 6A is an perspective view of a balloon of a catheter-based microneedle thermal ablation device;
[0038] FIG. 6B is a front view of the embodiment of FIG 6A;
[0039] FIG. 7A is an illustration of a prior art thermal ablation device and a first and a second embodiment of presently disclosed thermal ablation devices having curvilinear needles configured to treat internal solid organs;
[0040] FIG. 7B is an enlarged view of the first embodiment of the presently disclosed thermal ablation devices having one curvilinear needle;
[0041] FIG. 7C is an enlarged view of the second embodiment of the presently disclosed thermal ablation devices having multiple curvilinear needles;
[0042] FIG. 8 is a diagram depicting steps of a method of using a microneedle thermal ablation device;
[0043] FIGS. 9A-9P are graphs illustrating thermal simulations treating a cutaneous wart using existing devices and techniques over time;
[0044] FIGS. 10A-10P are graphs illustrating thermal simulations treating a cutaneous wart using one configuration of the disclosed microneedle thermal ablation device over time;
[0045] FIGS. 11A-9P are graphs illustrating thermal simulations treating a cutaneous wart using a second configuration of the disclosed microneedle thermal ablation device over time;
[0046] FIGS. 12A-12P are graphs illustrating thermal simulations treating a cutaneous wart using a third configuration of the disclosed microneedle thermal ablation device over time;
[0047] FIGS. 13A-13P are graphs illustrating thermal simulations treating a cutaneous wart using a fourth configuration of the disclosed microneedle thermal ablation device over time;HENK_100.100
[0048] FIG. 14 is a graph illustrating probe depths for FIGS. 15-19;
[0049] FIG. 15 is a graph summarizing the temperature results of the simulation from FIGS. 9A-9P that simulate treating a cutaneous wart with existing thermal ablation devices;
[0050] FIG. 16 is a graph summarizing the temperature results of the simulation from FIGS. 10A-10P that simulate treating a cutaneous wart using one configuration the disclosed microneedle thermal ablation device over time;
[0051] FIG. 17 is a graph summarizing the temperature results of the simulation from FIGS. 11A-11P that simulate treating a cutaneous wart using a second configuration the disclosed microneedle thermal ablation device over time;
[0052] FIG. 18 is a graph summarizing the temperature results of the simulation from FIGS. 12A-12P that simulate treating a cutaneous wart using a third configuration the disclosed microneedle thermal ablation device over time;
[0053] FIG. 19 is a graph summarizing the temperature results of the simulation from FIGS. 13A-13P that simulate treating a cutaneous wart using a fourth configuration the disclosed microneedle thermal ablation device over time.DETAILED DESCRIPTION
[0054] Various example embodiments of a conductive thermal ablation device and methods of use thereof are disclosed and described in detail herein.
[0055] An understanding of heat transfer is central to the understanding of the disclosed devices and methods. Fourier’s Law governs heat transfer:
[0056] Where heat flux <E>q^ through the normal of a surface, thermal conductivity k, gradient operator V, and temperature T. Integrating over any material’s surface 5, Fourier’s Law becomes:
[0057] The left-hand side of this equation can be understood as the thermal power Q (in Watts):HENK_100.100
[0058] This is the time derivative of heat flow Q. The one-dimensional solution of the heat flow rate between two locations in space can be written as:
[0059] with surface area A, time / , distance / ., and temperature T.
[0060] These thermal transfer equations demonstrate key principles of thermodynamics. First, heat flows from areas of higher temperature to areas of lower temperature. Systems tend toward thermodynamic equilibrium, so when two substances with different temperatures come into contact, the molecules in the hotter substance will transfer energy in the form of heat to the molecules in the cooler substance.
[0061] Second, the magnitude of thermal energy transfer is directly proportional to the thermal conductivity of the material. Metals, including steel, aluminum, and copper, have thermal conductivities (“ks”) of 45 Win 'K’1, 235 W / m-K, and 398 W / m-K, respectively and are -100 to 1000 times more thermally conductive than human skin, which has a k of around 0.40 W / m-K.
[0062] Third, heat flow within a system increases proportionally with the surface area of the conductive material. Thus, increasing the surface area between two materials in contact increases heat transfer between the materials.
[0063] For cryotherapy applications, target tissue is destroyed by intracellular water ice crystals that form upon freezing. Thermal ablative devices rely on the superficial or isolated diffusion of heat from the body towards the cold temperature delivery by the device, such as a cryosurgery spray (i.e., liquid nitrogen) for dermatologic lesions or an internal needle cryoprobe for internal tumors, for example. Applying the insights regarding thermal conductivity and surface area mentioned above, the amount of net heat transfer from the thermal source (whether for thermal or cryo-ablation) into contacted tissue is not increased by a generally flat, two-dimensional thermal ablation device. Use of a thermal ablation device with a three-dimensional microstructure, however, can greatly increase the conductive surface area between a thermal or cryotherapy probe and the tissue.
[0064] In a common prior-art example, internal cryoablation is performed using a hollow cryoprobe. The cryoprobe is inserted into the tissue to be ablated, such as a hepatic, renal, or other solid-organ tumor. Radiographic, ultrasound, or stereotacticHENK_100.100guidance is used to properly position the cryoprobe. Following confirmation of proper placement, liquid nitrogen is circulated through the distal end of the probe, which may be a hollow sphere or cylinder. Heat flows from tissue in contacting the surface of the probe through the wall of the probe to the liquid nitrogen, freezing a rim of tissue contacting the probe’s distal end. Thereafter, heat flows sequentially from a rim of unfrozen tissue through the frozen tissue and into the probe. As the circulating liquid nitrogen continues to carry heat away from the probe, an “ice ball” of frozen tissue progressively enlarges. This is problematic for at least two reasons. First, the distal probe is essentially a point-source having limited surface area for heat transfer from the surrounding tissue into the probe. Second, tissue, whether frozen or not, tissue has very low thermal conductivity compared to a metal cryoprobe. Consequently as the frozen tissue mass grows, heat must flow a greater distance through low-conductivity tissue to reach the probe where it is carried away by the circulation. The amount of heat entering the probe progressively decreases as the frozen tissue mass enlarges. This is both inefficient and the changing heat transfer rate makes control of the ablation boundary difficult.
[0065] The conducive thermal ablation devices disclosed herein overcome these difficulties by expanding the cry oprobe surface area in contact with the target tissue providing more precise control and customization of the tissue ablation boundary.
[0066] Further, the techniques disclosed herein can be used to destroy a variety of unwanted tissue on or in the body. For example, techniques disclosed here can destroy benign, pre-malignant, and malignant tissue throughout the body. For example, a cryotherapy gun tipped with the microneedle device is used to destroy focal skin lesions with precise control. In some embodiments, the microneedle device threads onto a threaded cryotherapy gun tip. In some embodiments, the microneedle device snaps onto a cryotherapy gun tip configured with a complementary surface feature for removably receiving the microneedle device.Definitions:
[0067] For the purpose of these descriptions, certain terms should be afforded their broadest reasonable meaning as interpreted by a person of skill in the art. For example, “optionally” is intended to introduce a non-limiting example. The phrases “in one embodiment” and “in some embodiments” do not necessarily refer to the same embodiment(s), although they may. Furthermore, the phrases “in anotherHENK_100.100embodiment” and “in some other embodiments,” as used herein, do not necessarily refer to a different embodiments, although they may. The various example embodiments as described herein may be readily combined without departing from the scope or spirit of the disclosed inventions. The term “or” unless otherwise specified, is inclusive and is equivalent to “and / or.” The term “based on” is not exclusive and allows for use based on additional factors not described unless the context clearly dictates otherwise. Throughout the written description, the meaning of “a,” “an,” “and “the” include plural references. The meaning of “ion” includes “in” and “on.” The terms “comprises” and “comprising,” as used herein, specify that certain features are present in the described embodiment(s), however this phrase should not be interpreted to preclude the presence or addition of additional step, operations, features, components, and / or groups thereof.
[0068] As used herein, “heat transfer” is the process by which thermal energy is exchanged between physical systems. Heat transfer occurs whenever there is a temperature difference between objects or media. Heat transfer is a fundamental principal in thermodynamics and informs the design and parameters of systems and devices where thermal management is essential, such as heating and cooling applications of the present disclosure. There are three modes of heat transfer: conduction, convection, and radiation. As used herein, “conduction” means heat transfer through direct contact between molecules, where vibrations are passed from one molecule to the next. As used herein, “convection” means the transfer of heat by the physical movement of a fluid, meaning liquid or gas, which carries thermal energy from one location to another. As used herein, “radiation” means the transfer of heat in the form of electromagnetic waves through a vacuum or transparent medium.
[0069] As used herein, “conductive” applies to the thermal transfer property of a material. Regarding the present disclosure, a conductive material is a substance that facilitates efficient movement of thermal energy through its structure. A material with high thermal conductivity, as measured in watts per meter-kelvin (“W / m-K”), transfers thermal energy more efficiently than materials with lower thermal conductivity. For example, metals have relatively high thermal conductivities with steel having a thermal conductivity of 45 W / m-K. Whereas wood, a relatively poor thermal conductor, has a thermal conductivity of 0.15 W / m-K.
[0070] As used herein, “thermal ablation” means a process where tissue is destroyed using thermal energy. Thermal ablation refers to both the use of either low (cold) orHENK_100.100high (hot) temperatures relative to body temperature to destroy tissue. In thermal ablation applications, very low temperatures are far below and very high temperatures are far above human or animal body or tissue temperature which typically ranges between 32°C and 38°C. Precise temperatures administered by the disclosed thermal ablation devices are provided in more detail below. Further, “thermal ablation” and “thermal delivery” are used interchangeably to describe devices and processes that deliver hot or cold temperatures to target tissues.
[0071] Depending on the location and type of tissue, thermal ablation can be performed percutaneously through skin contact, use of an intraluminal approach such as endoscopic, endo-bronchial, or endovascular approach, or surgical whether traditional “open” surgery, laparoscopic, or thoracoscopic approaches. Devices used to perform thermal ablation procedures utilize various energy sources. For example, heating thermal ablation devices incorporate resistive, induction, radiofrequency, microwave, laser, or thermoelectric effect heating mechanisms to perform thermal ablation. These heating thermal ablation mechanisms are described in more detail below.
[0072] Resistive thermal ablation methods send electric current through a resistive material where electrical energy is converted into thermal energy. This process is known as “Joule heating.” Thermal ablation by induction utilizes an alternating magnetic field generated by an induction coil to produce eddy currents in a material which are converted into heat due to electrical resistance. Induction heating does not require direct contact between the device and biological tissue. Radiofrequency thermal ablation uses radiofrequency generators to send high-frequency electrical currents, typically ranging between 450 and 500 kHz, to electrodes that heat up due to resistive heating. Radiofrequency ablation requires direct contact between the electrode and the biological tissue.
[0073] Microwave thermal ablation uses electromagnetic waves, typically 915 MHz or 2.45 GHz microwaves, to agitate water molecules in biologic tissue, generating heat through dielectric heating. Microwave heating has the ability for deeper tissue penetration compared to RFA and can treat larger ablation zones. Laser thermal ablation uses focused laser beams to send high-energy light to targeted biologic tissues that absorb the energy, and result in rapid heating and tissue death. Laser thermal ablation involves highly costly and complex equipment. Thermoelectric effect heating ablation relies on the Peltier effect. When an electric current passes throughHENK_100.100the junction of two dissimilar conductive materials, heat is either absorbed or released at the junction, depending on the direction of the current. For heating ablation, the current is set to generate heat at the thermoelectric junction to treat target tissue.
[0074] Cooling “cryotherapy” thermal ablation devices include thermoelectric effect and cryogenic cooling devices. As described above, thermoelectric effect devices pass electric current through the junction of two dissimilar conductive materials. In cooling applications, the direction of the current is adjusted to result in heat absorption at the junction. When applied to target tissue, cooling thermoelectric effect devices remove heat from the target tissue, lowering its temperature and resulting in tissue destruction.
[0075] Cryogenic cooling devices, also referred to as “cryotherapy devices” deliver cryogens, substances that produce very low temperatures, to a target tissue. Common cryogens in medicine include liquid nitrogen, carbon dioxide snow, and argon gas which produce temperatures of -196°C, -78.5°C, and -160°C, respectively. During cooling thermal ablation, water within target tissue cells freezes, producing ice crystals that expand in volume and disrupt cell membranes, resulting in cell death. Common cryogenic thermal ablation devices include cryoprobes and cryospray devices.
[0076] As used herein, “cryoprobes” means instruments that use a thin, hollow device to deliver cryogens to target tissue. As used herein, “cryospray devices” means instruments that spray cryogens directly onto the surface of target tissue. Cryospray devices typically have reservoirs to store cryogenic fluid, nozzles to disperse a cryogen spray, and control systems to regulate the flow of cryogens through the device. Common commercial cryospray devices include handheld pens, such as the CryoPen® (Cryopen, Inc., Corpus Christi, Texas), and larger spray cannister devices such as Brymill® cryogenic systems (Brymill Corporation, Ellington, Connecticut).
[0077] As used herein, “microneedle” refers to micro-sized needles, generally distributed in an array forming various two-dimensional shapes, including polygonal shapes, curvilinear shapes, and combinations thereof. Microneedles pierce the upper layer of skin, the stratum comeum to enter or, in some embodiments, extend through the epidermis layer. Microneedles have relatively short lengths and small diameters, whereunder piercing of skin layers is typically painless or almost painless. While microneedles can be hollow and porous for use in drug delivery and biofluid sampling applications, microneedles of the present disclosure are used to facilitate thermal transfer applications and are usually configured as solid structures.HENK_100.100
[0078] As used herein, “intradermal” means within or between the layers of skin and “intradermally” means administered by entering the skin.
[0079] As used herein, “microprobe” means a small, needle-like device that is used in medicine to deliver focused thermal energy directly to treat targeted tissue.
[0080] As used herein, “user” refers to a clinician qualified by training to perform thermal ablation procedures. Examples include doctors, surgeons, oncologists, gynecologist, dermatologists, and others.
[0081] As used herein, directional references with respect to any of the several drawing figures, such as top, bottom, left, right, front, rear, upper, lower, and the like, for example, are intended for convenience of description to add clarity with reference to the object, region, or element discussed and is not intended to limit present disclosure or a component to a particular positional or spatial orientation.
[0082] As used herein, “proximal” means nearer to the user or further from the patient. “Proximal” means disposed more proximate to the user of a conductive thermal ablation device than one or more other structures.
[0083] As used herein, “distal” means away from the user; i.e., nearer to the patient, with respect to a conductive thermal ablation device or its individual components. The terms “distal” and “proximal” are used herein to relate the positions of structures with respect to one another using the user as a common reference point. The structures may include a conductive thermal ablation device or its individual components. For example, “proximal” means a structure or reference point of a conductive thermal ablation device which is disposed further from the patient (closer to the user) than a more “distal” structure of the conductive thermal ablation device. The relationship assumes the device is in use, however, the relative positions of the user and the patient are assumed regardless of whether a user or a patient are present.
[0084] Reference will now be made to various example embodiments as shown in the several drawing figures. One skilled in the art will readily recognize from the following descriptions that alternative embodiments of the structures and methods disclosed herein may be employed without departing from the principles of the inventions as described.
[0085] FIG. 1A is an perspective view of a prior art thermal ablation device, Medgyn MTA-100 Thermal Ablation System disclosed in U.S. Design Pat. No. Ser. No.914877S1. FIG. 1A shows prior art device 100 is a portable thermal ablation deviceHENK_100.100used to treat cervical lesions. Device 100 includes a smooth ablation tip 110 and electrical control hub 120. Ablation tip 110 reaches a temperature of about 100°C. To use the device, a user positions ablation tip 110 proximate the targeted tissue. The user then selects a time interval of 20, 40, or 60 seconds and starts the device to administer heat through ablation tip 110 to the targeted tissue. Ablation tips 110 of device 100 come in several sizes, but in each configuration, ablation tip 100 contacts only the surface of the targeted cervical tissue.
[0086] FIG. IB is a perspective view of a prior art cryotherapy device. FIG. IB shows a device 150, a Brymill CRY-AC®-3 handheld cryotherapy device configured to spray liquid nitrogen onto the surface of a skin lesion, such as a wart. Device 150 comprises a reservoir 160 containing liquid nitrogen, a handle 170, and a spray nozzle 180. When a user presses handle 170, liquid nitrogen travels from reservoir 160 through device 150 and exits the device through spray nozzle 180. A fine mist of liquid nitrogen is then dispensed onto the surface of the targeted tissue. Brymill offers several nozzle shapes, and every configuration produces a single layer of cryogenic liquid distributed onto the targeted tissue surface. Additional details about device 150 are found in U.S. Pat. No. 5,957,918 to Griswold.
[0087] The prior art devices shown in FIGS. 1A and IB both perform thermal ablation by delivering a cryogen to the surface of a target tissue, i.e., a skin lesion. However, device 100 and device 150 both provide limited ablation tip options and customization of the ablation boundary is nonexistent. This results in an inefficient and imprecise technique for treating a three-dimensional lesion or tumor. To address these inefficiencies, the present disclosure provides improved thermal ablation devices described in further detail below.
[0088] FIG. 2A is a perspective view and FIG. 2B is a front view of a thermal ablation device. FIGS. 2A and 2B show a thermal ablation device 200. Device 200 comprises a central body 210 having a first wall 230 and a contact wall 220. Device 200 further includes a plurality of microneedles 240. Each microneedle 240 has a microneedle base 242 and a microneedle tip 244. In some embodiments, base 242 of each microneedle 240 is coupled to contact wall 220 of central body 210.
[0089] In some embodiments, microneedles 240 and body 210 are manufactured as a unitary body Manufacturing techniques may comprise, for example, laser or photochemical micromachining, injection molding, three-dimensional printing processes including direct metal laser sintering (DMLS), and / or electron beamHENK_100.100melting (EBM). In some embodiments, device 200 is manufacturing using a combination of two or more of these processes. In some embodiments, microneedles 240 are manufactured separately from central body 210 then joined with central body 210 in a separate manufacturing step.
[0090] In some embodiments, device 200, body 210, and microneedles 240 are manufactured from solid, thermally conductive, biocompatible materials that can be sterilized for use in medical procedures. For example, in some embodiments, device 200 comprises aluminum, stainless steel, titanium, copper, gold, polycarbonate, polydimethylsiloxane, aluminum oxide, silicon carbide, polymer-metal composites, polymer-ceramic composites, graphene, carbon nanotubes, or a combination thereof.
[0091] To treat a variety of lesion sizes and geometries most effectively, device 200 is provided in many sizes, shapes, with a plurality of microneedle 240 configured into many different shaped microneedle arrays. In some embodiments, a plurality of microneedles 240 forms a planar array disposed upon contact wall 220. As shown in FIG. 2A, microneedles 240 form a square planar array on contact wall 220 comprising seven microneedles 240 along a length of the array and seven microneedles 240 along a width of the rectangular (square) example array. The example configuration has forty nine (49) total microneedles 240 on device 200.
[0092] To optimize thermal ablation of complex (non-planar) target tissue geometries, contact wall 220 presents a non-planar surface. In some embodiments, contact wall 220 presents a nonplanar surface forming a group of three-dimensional shapes consisting of a sphere, a hemisphere, a cone, a pyramid, a cylinder, a polygonal prism, or a combination thereof. For example, in some embodiments, contact wall 200 is configured as a conical surface to treat target tissues with voids or pockets, allowing contact wall 200 to fully contact the target tissue so microneedles 240 penetrate the target tissue at the same or similar depths.
[0093] FIG. 2C is a partial side view of a microneedle thermal ablation device 200.FIG. 2C shows three microneedles 240 from a section of device 200 taking from FIG. 2B to include dimensional details from device 200. Dimension LH is the overall length of microneedle 240, extending from base 242, ending in tip 244 opposite base 242. In some embodiments, such as shown in FIGS. 2A-C, LH is the same for each microneedle 240 within an array of device 200. In some alternative embodiments, LH varies across the array. For example, in some embodiments, LH is larger in the middle of the array and smaller at the periphery of the array. This example embodiment couldHENK_100.100be used to treat lesions having greater depth centrally and shallower depth peripherally, as will be discussed further below.
[0094] Dimension LB is a base width of microneedle 240. LB is referred to as the base width in the art in reference to microneedles 240 that have circular bases, such as those in FIGS. 2A-2C. However, in some embodiments, microneedles 240 are provided in a variety of base shapes including a non-circular ellipse, square, rectangle, or polygon. Accordingly, microneedles 240 are provided as cylindrical, pyramidal, or conical in some embodiments wherein tip 244 may be beveled.
[0095] Dimension Ls is the microneedle spacing length. Ls measures the distance between tips 244 of adjacent microneedles 240. In some embodiments, dimension Ls is the same value across the entire array of microneedles 240. In other embodiments, Ls varies across the array. For example, in some embodiments, Ls is smaller in the middle of the array and larger at the periphery of the array to treat lesions that have dense tissue in the middle and sparse tissue at the periphery. In another example, Ls is smaller at the periphery and very large in the middle of the array, to treat generally circular lesions.
[0096] Dimension DT is the diameter of microneedle tip 244. DT is optimized to various medical applications, balancing robust mechanical integrity with sharpness to reduce patient pain and increase ease of insertion. To accommodate a range of target tissue varieties and locations, DT may be 5, 10, 15, 20, 30, 40, 50, 60, 70, 80, 90, or 100 micrometers (pm). These values may be used to define discreet DT, such as 10 or 20 pm or ranges of DT, such as 20-30 pm. While most tips 244 are circular, in embodiments where tips 244 are not circular, DT represents the length of the microneedle tip 244 of microneedle 240.
[0097] FIG. 2C additionally shows a central axis 250 extending along LH of microneedle 240. As shown, central axis 250 is a straight line. However, in embodiments wherein microneedle 240 is curved, central axis 250 is curvilinear.
[0098] Although FIGS. 2A-2C show thermal ablation devices comprising a plurality of microneedles 240 forming a rectangular array, device 200 is provided in additional embodiments. For example, in some embodiments, device 200 comprises two- dimensional planar arrays from a group of shapes consisting of a circle, an ellipse, a triangle, a rectangle, a polygon, or a combination therebetween.
[0099] In some embodiments, thermal ablation device 200 comprises an array of microneedles 240 configured to maximize target tissue penetration depth and areaHENK_100.100while minimizing procedure time. This is important for minimizing any pain a patient may feel during a thermal ablation procedure. Additionally, it is advantageous to use device and patient data throughout different use-cases, including gross images, pathology, imaging techniques to train an artificial intelligence model to provide optimized tissue treatment procedures.
[0100] FIG. 2D is a side view of an alternative embodiment of a microneedle thermal ablation device. FIG. 2D shows a microneedle array having a plurality of microneedle 240 lengths. To accommodate different sizes and shapes of target lesions, in some embodiments, thermal ablation device 200 includes microneedles 240 having differing dimensions across one or more dimensions of the array as shown in FIG. 2D. FIG. 2D shows an embodiment of thermal ablation device 200’ having a central body 210’, a first surface 230’, a contact surface 220’, and microneedles 240’, wherein the length LH of microneedles 240’ varies across the array. At the periphery of the array, LH is small relative to length LH in the center of the array. Length LH is larger near the center of the array relative to the periphery, wherein length LH of microneedles 240’ forms a gradient of lengths LH across the array. In some embodiments, microneedle length LH varies across the array to collectively form a nonplanar microneedle tip 244’ array. In some embodiments, the nonplanar array of microneedle tips 244’ forms a hemispherical surface curve. In some embodiments, the nonplanar array of microneedle tips 244’ forms a cylindrical surface curve. In some embodiments, the nonplanar array of microneedle tips 244’ forms a semi -lenticular surface curve. In some embodiments, the nonplanar array of microneedle tips 244’ forms a wave-like, undulating pattern.
[0101] FIG. 3A is a cross-sectional view of a cutaneous wart treated with a prior art thermal ablation device. FIG. 3A shows device 150 (shown in FIG. IB) contacting the surface of a target lesion 310. .Embodiments of thermal ablation devices 200 and 200’ are configured for use on a variety of dermal and internal target tissue lesions for greater treatment efficacy than existing devices. In one example, FIGS. 3A and 3B show the difference between the application of prior art and presently disclosed thermal ablation devices on common skin lesions, cutaneous warts. FIGS. 3-B show a cross section through a tissue layer 300, such as a skin dermis, in some embodiments. FIGs. 3A-B also show a target tissue 310 and an ablation boundary 330. Target tissue 310 may be a cutaneous wart, a skin cancer, or similar skin lesion. Device tip 180 of prior art device 150 is positioned contacting an external surface of aHENK_100.100mass of target tissue 310. A user actuates flow of a cryogenic fluid, such as liquid nitrogen, from device tip 180 creating a fluid stream 190 that inundates the surface of target tissue 310. With such prior art thermal ablation devices configured to effect heat transfer only at the surface of target tissue 310, including device 150, ablation boundary 330 extends a short distance into tissue layer 300. Device 150 only partially ablates target tissue 310, failing to treat much of the root of target tissue 310 that extends more deeply into tissue layer 300. Leaving a deeper portion of target tissue 310 untreated permits regrowth of the lesion, thus requiring multiple treatment sessions to complete ablation of target tissue 310. Embodiments of the thermal ablation devices disclosed herein overcome this drawback.
[0102] FIG. 3B is a cross-sectional view of a cutaneous wart treated with a conductive thermal ablation device. FIG. 3B shows device 200 applied to target tissue 310 such that contact surface 220 contacts target tissue 310 and microneedles 240 penetrate target tissue 310. Because physical contact between the thermal conductor comprising a plurality of microneedles 240 is greatly increased over prior art devices, such as device 150 shown in FIG. 3 A, ablation boundary 330 produced by device 200 is significantly larger than ablation boundary 330 in produced by prior art device 150. Heat transfer to or from lesion 310 from device 200 ablates a greater volume of tissue were contact time and temperature at the interface between device 200 and lesion 310 are constant because the contact surface area available for heat transfer between device 200 and lesion 310 is greatly increased versus a prior art device, as can be appreciated by examination of FIGs. 3A-B.
[0103] Conductive thermal ablation devices disclosed herein are provided in a variety of configurations for coupling conductive thermal ablation device 200 with existing thermal surgical tools and thermal ablation devices, in some embodiments. For example, existing thermal ablation devices may be a cryogenic device employing a cryogen such as liquid nitrogen or a cooling device utilizing the thermoelectric effect, such as a Peltier cooler. In some embodiments, the cryogenic source is liquid nitrogen or ethylene glycol. In a further example, the existing thermal ablation device comprises a heating device employing electric resistive heating, induction heating, radiofrequency heating, and / or heating from microwave, laser, or thermoelectric energy sources.
[0104] FIG. 4A is an perspective view of a microneedle applicator. FIG. 4A shows a microneedle applicator 400 configured for use in conjunction with existing thermalHENK_100.100ablation devices for treating skin lesions. Applicator 400 comprises a body 410 having a front wall 420 and a back wall 430. Body 410 is coupled to one or a plurality of handles 440. In some embodiments, two handles 440 are coupled generally opposite one another to body 410, as shown in FIG. 4A. In some embodiments, a reservoir 450 is formed into back wall 430. A thermal ablation device 200, such as device 200 shown in FIGS. 2A-2C, in some embodiments, is coupled to body 410. FIG. 4B is a cutaway view of a microneedle applicator wherein conductive thermal ablation device 200 has been inserted.
[0105] Body 410 and handle 440 are configured having shapes and dimensions to treat multiple target lesion types and / or to conform to clinician user preferences. In some embodiments, body 410 comprises a flat, circular disc and handles 440 are coupled to the disc protruding laterally outwards at an angle of about 45° from first wall 420. In some embodiments, handles 440 are curved to enhance their surface area and facilitate user grip. In some embodiments, applicator 400 is configured to accommodate a wide range of ablation device 200 shapes and dimensions. In some embodiments, handles 440 are adjustably coupled to body 410 such that the user can change the angle between handle 440 and body 410. In some embodiments, handle 440 is fixedly coupled to body 410, In some embodiments, one or more handles 440 and body 410 are formed as a unitary body.
[0106] Microneedle applicator 400 is formed to receive device 200 therein such that contact wall 220 of device 200 is generally flush with front wall 420 of applicator 400. Additionally, in some embodiments, a reservoir 450 is formed as a cavity within back wall 430. Reservoir 450 may have a generally cylindrical shape or a frustral shape with tapered side walls. In some embodiments, reservoir 450 comprises alternative curvilinear sides or planar sides. During use of applicator 400, front wall 420 is positioned facing the target tissue and back wall 430 is positioned facing away from the target tissue, wherein device 220 contacts the target lesion. After positioning, the user advances applicator 400 until microneedles 240 penetrate the target lesion. A cryogenic liquid, such as liquid nitrogen, is placed into reservoir 450 such that the liquid cryogen contacts first wall 230 of device 200. Reservoir 450 is thermally coupled to body 210 of device 200, either directly as just described or indirectly through a layer of material having a high thermal conductivity interposed between first wall 230 and reservoir 450. The thermally conductive nature of device 200 facilitates thermal communication between the cryogen in reservoir 450 andHENK_100.100microneedles 240, enabling heat transfer from the target lesion and ablative freezing thereof.
[0107] To limit the thermal ablation contact area between applicator 400 and normal skin or other tissue surrounding the target lesion, body 410 of applicator 400 is made from a thermal insulator having low thermal conductivity. For example, in some embodiments, body 410 comprises thermally insulating plastics such as polypropylene (PP) and polycarbonate (PC) that have thermal conductivities of 0.1- 0.22 W / m-K and 0.2 W / m-K, respectively. In some embodiments, body 410 comprises ceramics and polymer-ceramic composites having similar or lower thermal conductivities as PP and PC. Other low-thermal conductivity materials or composites may be used.
[0108] Applicator 400 is useful for treating target skin lesions such as condolomata including common skin warts, genital warts, and perianal warts; benign skin growths such as seborrheic keratoses, skin tags, cherry angiomas and solar lentigos; and malignant or pre-malignant lesions including lentigo maligna, actinic keratoses, squamous cell carcinomas, basal cell carcinomas, and malignant melanoma. In some embodiments, applicator 400 is configured for use in combination with existing thermal ablation devices, such as device 100 and device 150, for example, using cytoablative or heat-ablative techniques. In some embodiments, applicator 400 comprises a fixation means to removably affix it to the target tissue or to an existing thermal ablation device. For example, in some embodiments, front surface 420 is fully or partially coated with an adhesive to enable a secure but removable connection between applicator 400 and a patient’s skin. In some embodiments, back wall 430 is removably coupled to a prior art thermal ablation device.
[0109] FIG. 5A is an perspective view of an additional embodiment of a microneedle applicator for treating multiple dermal lesions. FIGS. 5A-5B show an applicator tip 500 configured for use of thermal ablation device 200 with existing thermal surgical tools and devices. Applicator tip 500 comprises body structure 510. Body structure 510 is dimensioned to couple with thermal ablation device 200 to a front wall 520 of body structure 510. Body structure 510 comprises a first wall 530 within an interior defined by one or more side walls 540 and a front wall 520 positioned proximate to a target lesion or tissue. Applicator tip 500 further comprises ablation device 200 having a plurality of microneedles 240 wherein each microneedle 240 has a base 242 coupled to contact wall 220 and a length LH extending from base 242 ending in tipHENK_100.100244 opposite base 242. Applicator tip 500 further includes an attachment means configured to removably couple central body 510 to a thermal delivery device.
[0110] FIG. 5B is a cutaway view of the embodiment of FIG 5A. FIG. 5B shows a back wall 530, a side wall 540, a front wall 520, and a reservoir 550 of applicator tip 500. Similar to body 410 of applicator 400, body structure 510 of tip 500 is provided in a variety of shapes and sizes to accommodate multiple target tissue types, surgical devices, and user preferences. For example, central body 510 is provided in small, medium, and large sizes to best suit small, medium, and large target tissues, respectively. In some embodiments, central body 510 comprises a tapered, hollow cylinder with device 200 coupled to second wall 520. In some embodiments, tip 500 is configured to receive device 200, as shown in FIGs. 5A-B. In some embodiments (not shown), tip 500 and elements of device 200 are formed as a single unitary body.[OHl] In some embodiments, applicator tip 500 comprises an attachment means coupled to first wall 530 and / or side wall 540. For example, applicator tip 500 may be threaded and / or comprise, a latch, a button, a tongue and groove fittings, a hook-and- loop attachment means, or a flexible, snap-on mechanism for removably connecting applicator tip 500 to existing pen or catheter-type surgical devices. Applicator tip 500 is further configured to accommodate a wide range of ablation device 200 sizes and shapes.
[0112] In some embodiments, body 510 comprises a reservoir 550 positioned within central body 510 extending from first wall 230 of thermal ablation device 200 to first wall 530 of applicator 500. Reservoir 550 is thermally coupled to body 210. In some embodiments, reservoir 550 comprises a cylindrical or tapered (frustum) shape. During use, thermal ablation device applicator 500 is coupled to a thermal ablation pen or catheter-type device using the attachment means proximate first wall 530 and / or side wall 540. Front wall 520 is then placed in contact with tissue surrounding the target lesion. A user then advances applicator tip 500 until microneedles 240 penetrate the target lesion. Next, the user activates the thermal ablation pen or catheter-type device coupled to applicator tip 500 to deliver a thermal load to reservoir 550 which conducts heat to (heat ablation) or from (cryoablation) first wall 230. As discussed at length herein above, the thermally conductive nature of device 200 facilitates heat transfer between the thermal load in reservoir 550 and microneedles 240 causing thermal ablation of the target lesion.HENK_100.100
[0113] To limit the thermal ablation contact area between applicator 500 and the patient and to promote user safety, body structure 510 is formed from a material that is a poor thermal conductor thus limiting thermal conduction to fist wall 230 facing reservoir 550 within applicator tip 500. For example, in some embodiments, both structure 510 comprises thermally insulating plastics such as polypropylene (PP) and polycarbonate (PC) that have thermal conductivities of 0.1-0.22 W / m-K and 0.2 W / m-K , respectively. In some embodiments, body 510 comprises ceramics and polymer-ceramic composites having similar or lower thermal conductivities as PP and PC.
[0114] Applicator 500 is useful for treating external skin lesions. Non-limiting examples include common skin warts, genital and / or perianal condylomata, seborrheic keratoses, skin tags, cherry angiomas, solar lentigos, lentigo maligna, actinic keratoses, squamous cell carcinomas, basal cell carcinomas, malignant melanomas, and the like. Applicator tip 500 can be used in combination with existing thermal ablation devices, such as thermal ablation pens and thermal ablation catheters well suited for treating patients with multiple target lesions.
[0115] FIG. 6A is an perspective view of a balloon of a catheter-based microneedle thermal ablation device 600. FIGS. 6A-6B show an additional example embodiment of a thermal ablation device 600 having a collapsable balloon 610. FIG. 6B is a side view of the embodiment of FIG 6A. Balloon thermal ablation device 600 comprises central body provided as an inflatable balloon 610. Balloon 610 has a contact surface 620 which is formed by an outer (tissue-facing) surface of balloon 610.
[0116] In some embodiments, balloon 620 is provided in a variety of shapes, such as a . tapered balloon, a spherical balloon, a bilobed dumbbell-shaped balloon, a stepped balloon, and an offset balloon, for example. In some embodiments, balloon 620 comprises a combination of inflatable catheter balloon shapes which will be appreciated by a person of skill in the medical device arts. For example, central body 610 comprises a conical / cylindrical long balloon, a coni cal / spheri cal long balloon, or an offset conical balloon.
[0117] In some embodiments, the plurality of microneedles 240 coupled to contact surface 620 are movable between a first (retracted) position when balloon 610 is in an unexpanded state and a second (extended) position when balloon 610 is in an expanded state. Microneedles 420 are folded flat against surface 620 of balloon 610 when balloon 610 is collapsed, wherein the plurality of microneedles 420 areHENK_100.100constrained folded flat in the first position by a surrounding catheter sheath or trocar sheath such as used with trans-catheter vascular interventional procedures and laparoscopic / thoracoscopy procedures, respectively. The catheter device is configured to be placed laparoscopically, endoscopically, or endovascularly. For use, balloon 600, is coupled to a catheter and configured to be deployed from a distal end of a catheter sheath positioned proximate to a target lesion or tissue. When a distal end of the catheter sheath is in the desired position, the sheath is withdrawn from device 600, allowing the plurality of microneedles 240 to transition into the second, extended position upon inflation of balloon 610. In some embodiments, the shape arrangement (surface array) of microneedles 240 on balloon 610 is configured to provide directionality of heat transfer.
[0118] In some embodiments, device 600 is deployed using a flexible catheter or a rigid-stereotactic method. For the deployment, this can include preset wires, spikes, or needles that pierce a hemispherical or cylindrical cap of device 600. In some embodiments, microneedles 240 pierce the cap of device 600 through thimble-like hole openings, or alternatively through an inflatable balloon. In some embodiments, microneedles 240 are deployed by an actuator system similar to a system of pulleys and cables used laparoendoscopic surgical instruments.
[0119] In some embodiments, device 600 is used in conjunction with specialized catheters or probes that utilize a cryogenic fluid, including, for example, liquid nitrogen, argon gas, and others. Liquid nitrogen flows through an insulated system to device 600 to conduct cold temperatures to the tissue in contact with surface 620 and / or microneedles 240. In some embodiments, the cryogenic fluid is delivered via endovascular or endoscopic systems. Alternatively, for argon gas and liquid nitrogen applications, small quantities of argon gas or liquid nitrogen is transported directly into the target lesion through microneedles 240 having open tips 244. This configuration enables vaporization and heat absorption for liquid nitrogen and the Joule-Thomson effect for argon gas.
[0120] Additional embodiments of the presently disclosed thermal ablation device are shown in FIGS. 7A-7C. Microwire thermal delivery devices in the field are advanced medical tools that use ultra-thin wires, also referred to as microwires, to deliver or control thermal energy in precise locations within the body. These devices are frequently used in applications requiring localized heating or cooling, including thermal ablation procedures. The microwires typically have diameters between 10-HENK_100.100100 pm and are made from materials with high thermal conductivity. They are designed for use in minimally invasive procedures. The small size of microwires enables ablation of highly localized targeted tissues, cells, or regions. Microwires are used in oncology to deliver heat to tumors, enhancing the effectiveness of chemotherapy or radiation therapy. They are also used for precise thermal ablation of non-neoplastic abnormal tissues, for example in cardiac arrhythmia treatment.
[0121] FIG. 7A is an illustration of a prior art thermal ablation microwire device including a first and a second embodiment of presently disclosed thermal ablation devices having curvilinear needles used to treat targeted lung tissue. FIG. 7A shows a patient 700 with lungs 701. Lungs 701 comprise three target tissue sites, a first site 706, a second site 710, and a third site 720. In some embodiments, first tissue site 706 comprises a single lesion 708, second tissue site 710 comprises a single, oblong lesion 712, and third tissue site 720 comprises three distinctly shaped lesions 722, 724, and 726. Second tissue site 710 is shown in detail in FIG. 7B. Third tissue site 720 is shown in detail in FIG. 7C.
[0122] FIG. 7A shows a prior art microwire device 702 having a microwire 704.Microwire 704 is provided in a straight configuration. Although it penetrates lesion 708, the straight configuration of microwire 704 does not align with the spherical, dimpled shape of lesion 708. Thus, prior art microwire device 702 reaches lesion 708, but does not evenly heat or cool the length of irregularly shaped lesion 708. Uneven ablation of lesion 708 results in either incomplete ablation of the target lesion, ablation, and damage to surrounding normal tissue, or both. In the case of a lung tumor, incomplete lesion ablation leaves viable tumor cells in patient 700 which can multiply and may metastasize, making patient 700 more ill. Therefore, to better accommodate different sizes and shapes of a target tissue, the present disclosure provides thermal ablation devices having nonlinear wires and needles.
[0123] FIG. 7B is an enlarged view of a first embodiment 714 of the presently disclosed thermal ablation devices having a single curvilinear wire or needle 716. As shown in FIG. 7B, second tissue site 710 includes a single, irregularly shaped oblong lesion 712. In some embodiments, lesion 712 is a lung tumor. Thermal ablation device 714 is a thermal ablation catheter-based device utilizing microwave energy and having curvilinear wire or needle 716 at its distal tip. A user inserts device 714 with needle 716 in a retracted position. Once the distal end of device 714 is appropriately positioned proximate to lesion 712, the user deploys needle 716 into lesion 712 usingHENK_100.100radiographic or stereotactic means to position needle 716 centrally within lesion 712 Next, the user engages the thermal ablation mechanism of device 714 to increase the temperature of needle 716, delivering a thermal load to lesion 712. Needle 716 heats lesion 712 through a central path that produces even heat transfer through lesion 712, thus providing a more precise thermal delivery mechanism than prior art microwire thermal ablation devices.
[0124] FIG. 7C is an enlarged view of the second embodiment 728 of the presently disclosed thermal ablation devices having multiple curvilinear wires or needles 730. In some embodiments, device 728 includes multiple long needles or wires 730 disposed at a distal end of a catheter-based ablation device that are positioned by stereotactic means for deep tissue destruction. As shown in FIG. 7C, a second tissue site 720 includes three distinctly shaped lesions: a lesion 722, a lesion 724, and a lesion 726. In some embodiments, lesions 722, 724, and 726 are lung tumors requiring thermal ablation treatment. Microwire thermal ablation device 728 is a thermal ablation catheter having multiple curvilinear wires or needles 730 at its distal tip, in some embodiments. Such embodiments are useful when multiple tumor foci are present in area that also includes normal tissue and are best targeted by heat-transfer ablation using multiple curvilinear wires or needles 730.
[0125] A user inserts device 728 with needles 730 in a retracted position. Once the distal end of device 728 is appropriately positioned at second tissue site 720, the user deploys needles 730 into lesions 722, 724, and 726 using radiographic or stereotactic means such that each needle 730 extends through the middle of each lesion. Next, the user engages the thermal ablation mechanism of device 728, rapidly heating needles 730 to deliver a thermal load to lesions 722, 724, and 726. In this manner, a plurality of lesions are treated simultaneously, saving time and cost of the surgery while increasing the precision and effectiveness of the thermal ablation procedure.Accordingly, microwire thermal ablation devices 714 and 728 allow improved customization resulting in more complete lesion treatment while minimizing damage to intervening normal tissue. Although the target lesions shown in FIGS. 7A-7C are located in lungs 701, simultaneous use of multiple nonlinear thermal ablation wires 730 in other anatomic areas is contented, such as use in hepatic, renal, cardiac, brain, and other solid organs.
[0126] In some embodiments, the disclosed thermal ablation devices utilize heat ablation by quickly producing hot temperatures deep within a target tissue site.HENK_100.100However, it can also be used to cauterize tissue or wounds quickly. The presently disclosed thermal ablation devices and methods are particularly well-suited for treating internal bleeding within a solid organ in addition to cauterization of external bleeding sites. The microneedle devices of the present disclosure, in some embodiments, are used as cauterizing tools designed for precise surgical and traumatic applications, which would stop bleeding from capillary to small and medium-sized vessels. These microneedle devices can be deployed both during surgery or non- surgical situations such as traumatic or emergent situations like paramedics, emergency medical services (EMS), both on the battlefield and in military field hospitals.
[0127] The heat equations disclosed above dictate that microneedle devices would provide increased penetration and cauterization when compared with existing electrocautery devices. An induction heating means used with the disclosed microneedle devices, such as device 600, would instantly generate heat within the metal microneedles 240 such that microneedles 240 placed within bleeding tissue deliver thermal energy in a penetrating way in contrast to surface application of prior art contact cautery devices. In some embodiments, microneedle devices disclosed herein utilize an induction heating means, such as by placing a magnetic solenoid / coil coupled to a shaft contacting microneedles 240.
[0128] The key advantage held by the presently disclosed microneedle devices is precise, localized heating along the microneedle, reducing collateral tissue damage compared to traditional electrocautery methods. This application of the device is beneficial in applications including surgical hemostasis, minimally invasive dermatological procedures, animal model research of wound healing and nerve ablation.
[0129] FIG. 8 is a diagram depicting steps of a method 800 of using a microneedle thermal ablation device. FIG. 8 shows an obtaining step 810, a coupling step 820, a contacting step 830, an activating step 840, a deactivating step 850, and a removing step 860, in some embodiments.
[0130] Obtaining step 810 comprises obtaining a thermal ablation device having a central body coupled to a plurality of microneedles. In some embodiments, the thermal ablation device having a central body coupled to a plurality of microneedles comprises device 200, device 200’, device 400, device 500, device 600, device 714, or device 728 of the present disclosure.HENK_100.100
[0131] Coupling step 820, in some embodiments, comprises coupling a thermal delivery device configured to deliver a thermal load to the thermal ablation device. In some embodiments, the thermal load delivered by the thermal delivery device is a cryogenic fluid. In some embodiments, the thermal load is an energy sources. For example, the thermal load may comprise a resistive, an induction, a radiofrequency, a microwave, a laser, or a thermoelectric energy source.
[0132] In further example, cooling thermal loads include thermoelectric effect and cryogenic cooling means. Cryogenic cooling devices, also referred to as “cryotherapy devices” deliver cryogens, substances that produce very low temperatures, to target tissue. Common cryogens in medicine include liquid nitrogen, carbon dioxide snow, and argon gas which produce temperatures of -196°C, -78.5°C, and -160°C, respectively. During cooling thermal ablation, water within target tissue cells freezes, producing ice crystals that expand in volume and disrupt cell membranes, resulting in cell death. Common cryogenic thermal ablation devices include cryoprobes, cryopens, and cryospray devices.
[0133] Contacting step 830, in some embodiments, comprises contacting a target tissue surface with the thermal ablation device wherein the microneedles penetrate through a tissue surface into the target tissue. The target tissue is any tissue requiring thermal ablation treatment, whether by high or low temperatures. In some embodiments, contacting step 830 includes procedures performed on the skin surface. In some embodiments, contacting step 830 includes procedures performed internally. In some embodiments, contacting step 830 comprises contacting the thermal ablation device with a common skin lesion, such as a cutaneous dermal wart. In some embodiments, contacting step 830 comprises inserting the thermal ablation device into the body, for example, into the lungs, to treat target tissue within the lungs, such as lung tumor tissue.
[0134] Activating step 840 comprises activating the thermal delivery device causing a thermal load to be delivered to the central body for a time period. In some embodiments, activating step 840 is performed by energizing a thermal delivery device. In some embodiments, activating step 840 comprises delivery of a cryogenic fluid. The duration of activation is sufficient to treat the target tissue and is dependent on the size, location, and type of target tissue. For example, small dermal lesions can require substantially less than about sixty seconds of treatment using the thermal delivery device. In some embodiments, dermal lesions can require less than 1 second,HENK_100.100less than two seconds, less than 3 seconds, less than 5 seconds, less than 10 seconds, less than 15 seconds, less than 20 seconds, less than 25 seconds, less than 30 seconds, or less than 45 seconds of treatment using the thermal delivery device. In some embodiments, larger internal tumor target tissue can require more than about two minutes of treatment using the thermal delivery device. Other durations for treatment of dermal and internal tumor targets are contemplated as within the broad scope of the disclosures herein.
[0135] Deactivating step 850 comprises deactivating the thermal delivery device when the time period is complete. In some embodiments, the time period duration is informed by the size, shape, density, and location of the target tissue. In some embodiments, a user gathers additional data, such as imaging, radiology, and past thermal ablation procedures to establish the appropriate length of the time period.
[0136] Removing step 860 comprises removing the thermal ablation device from the target tissue surface. In some embodiments, step 860 comprises grasping the thermal ablation device and retracting it orthogonally from a surface of the target tissue. In some embodiments, removing 860 comprises withdrawing an internally applied thermal ablation device such that microneedles comprised by the device no longer penetrate the target tissue. In some embodiments, removing step 860 further comprises retracting the microneedles of the thermal ablation device into a catheter outer sheath, a endoscopic surgical trocar, or analogous sheathing element and withdrawing the device from the body of the patient.
[0137] In some embodiments, method 800 is used to treat cutaneous lesions, including a common skin wart, genital or perianal condolomata, a seborrheic keratosis, a skin tag, a cherry angioma, a solar lentigo, a lentigo maligna, an actinic keratosis, a uterine fibroid, an arteriovenous malformation, a squamous cell carcinoma, a basal cell carcinoma, or a malignant melanoma.
[0138] In some embodiments, the thermal ablation device used in method 800 is a multi-use device. In some embodiments, the thermal ablation device comprises a three-dimensional microneedle array forming a deep tissue conductive apparatus. In some embodiments, the microneedles are curvilinear.
[0139] In some embodiments, method 800 further comprises using radiographic, laboratory, and / or other data to improve thermal ablation. For example, the user can analyze gross images, pathology, imaging techniques, and any combination thereof to identify, characterize the properties of a lesion or lesions. Then the user can adjust theHENK_100.100geometry and parameters of the device and thermal settings to treat the targeted tissue most optimally.
[0140] In some embodiments, method 800 further comprises a calculating step wherein the time period is calculated to produce an ablation boundary having a depth, shape, and volume to include the target tissue and exclude a non-target tissue bordering the target tissue.Examples:
[0141] Example 1 includes thermal simulations developed to demonstrate the improvement of the presently disclosed thermal ablation devices over existing thermal ablation devices. Example 1 includes five thermal simulations. The first thermal simulation encompasses prior art devices and methods. The second through fifth thermal simulations encompass testing of different configurations of presently disclosed thermal ablation devices using microneedles.
[0142] Each simulation was performed using finite element modeling (FEM) in COMSOL Multiphysics® software to simulate the thermal behavior of a microneedle thermal ablation device inserted into skin. The thermal model utilized the fundamental heat conduction equation integrated with the bioheat equation to account for the thermal properties of skin and its interaction with the microneedle thermal ablation device.
[0143] The metal microneedle was modeled using stainless steel with its specific thermal conductivity, density, and heat capacity. The thermal properties and initial temperature of skin in the models were set to biologically accurate values. The simulations closely resemble the cutaneous wart treatment diagrams shown in FIGS.3A-3B
[0144] The primary COMSOL input geometry is provided in FIG. 14. FIG. 14 shows a graph of a target tissue and geometric simulation coordinates. A box 1410, located between [-2 mm, 2 mm] on the X-axis, and [0 mm, 1 mm] on the Y-axis, represents target tissue superficial to the dermis, in this case, a cutaneous wart. Below box 1410 is a box 1420 located between [-3 mm, 3 mm] on the X-axis, and [0 mm, -2 mm] on the Y-axis. The top of box 1420 indicates the superficial boundary of the dermis (dermal / epidermal junction) extending two millimeters in the -Y direction. Points 1450, 1460, 1470, and 1470 are point-temperature measurement locations used to summarize the simulation temperature results from FIGS. 9-13 and FIGS. 15-19.HENK_100.100Points 1450, 1460, 1470, and 1470 are taken at points [-0.5mm, 0mm], [-0.5mm, - 0.5mm], [-0.5mm, -1mm], [-0.5mm, -1.5mm], within dermis 1420 respectively, and correspond to legend symbols [+, ■, *, O].
[0145] Carefully established boundary conditions mimic realistic thermal ablation scenarios, including the interface between the microneedle and skin, heat transfer through convective and conductive mechanisms, and ambient environmental effects. Use of such boundary conditions also allowed for the simulation of applying a liquid nitrogen spray to the microneedle while inserted in the skin, enabling detailed analysis of the resulting rapid cooling effects. These parameters provide precise simulations of heat dissipation and temperature profiles, and insights into the thermal behavior of disclosed thermal ablation devices and methods in a biomedical context.
[0146] Each thermal simulation shown in FIGS 9-13 has X- and Y-axes with lengths in millimeters (mm) illustrating the geometric cross-section of a cutaneous wart box 1410 on skin box 1420. The thermal simulation figure also contains a legend displaying temperatures between 37°C and -196°C, where 37°C is represented as the darkest gray color and -196°C is represented as the white color. Shades of gray between these two endpoints are represented with darker colors indicating warmer temperatures in the simulation indicating and lighter colors indicating colder temperatures in the simulation. Note that the indicated temperatures of each shade of gray indicate a continuous temperature gradient across the gray band and not temperature changes in discontinuous steps. The temperature applied to both the surface of the wart box 1410 simulating the prior art cryospray device, and to the microneedles and central body simulating the presently disclosed thermal ablation devices was -196°C.
[0147] The prior art thermal ablation device and method shown in FIG. 3A, i.e., a cryo-spray device, was simulated over a period of zero to fifteen seconds and are shown in FIGS. 9A-9P. Specifically, FIG. 9A shows the simulation at zero seconds, FIG. 9B shows the simulation at one second, FIG. 9C shows the simulation at two seconds, FIG. 9D shows the simulation at three seconds, FIG. 9E shows the simulation at four seconds, FIG. 9F shows the simulation at five seconds, FIG. 9G shows the simulation at six seconds, FIG. 9H shows the simulation at seven seconds, FIG. 91 shows the simulation at eight seconds, FIG. 9J shows the simulation at nine seconds, FIG. 9K shows the simulation at ten seconds, FIG. 9L shows the simulationHENK_100.100at eleven seconds, FIG. 9M shows the simulation at twelve seconds, FIG. 9N shows the simulation at thirteen seconds, FIG. 90 shows the simulation at fourteen seconds, FIG. 9P shows the simulation at fifteen seconds. As shown in FIG. 9F, it takes five seconds for the temperature of the dermis in box 1420 to begin to change temperature due to the prior art cryospray device. Further, as shown in FIG. 9P, after fifteen seconds the lower millimeter of dermis box 1420 is still at body temperature, 37°C. This simulation demonstrates that using prior art cryospray devices does not deliver cold temperatures very far into the dermis which is necessary for complete wart removal.
[0148] Four configurations of a microneedle thermal ablation device like that shown in FIG. 2C having a three microneedles 240 and a thermally conductive central body 210 were modeled in a configuration similar to that shown in FIG. 3B over a period of fifteen seconds in FIGS. 10A-10P, 11A-11P, 12A-12P, and 13A-13P Each microneedle 240 in the thermal simulation figures has a LH of 2 mm. And the width of each central body 210 is 0.1 mm. For each of the four microneedle thermal ablation device simulation, the thermal ablation device was positioned on top of box wart 1410 such that contact surface 220 is adjacent to the top of wart box 1410 and microneedles 240 pierce wart box 1410 entirely, and 1 mm into dermis box 1420.
[0149] The thermal ablation device modeled in FIGS. 10A-10P has a first microneedle configuration. The first configuration includes three microneedles 240 having DT 0.1 mm, Ls 1.2 mm and LB of 0.2 mm. FIGS. 10A-10P show the simulation from zero to fifteen seconds. Specifically, FIG. 10A shows the simulation at zero seconds, FIG. 10B shows the simulation at one second, FIG. 10C shows the simulation at two seconds, FIG. 10D shows the simulation at three seconds, FIG. 10E shows the simulation at four seconds, FIG. 10F shows the simulation at five seconds, FIG. 10G shows the simulation at six seconds, FIG. 10H shows the simulation at seven seconds, FIG. 101 shows the simulation at eight seconds, FIG. 10J shows the simulation at nine seconds, FIG. 10K shows the simulation at ten seconds, FIG. 10L shows the simulation at eleven seconds, FIG. 10M shows the simulation at twelve seconds, FIG. 10N shows the simulation at thirteen seconds, FIG. 100 shows the simulation at fourteen seconds, FIG. 10P shows the simulation at fifteen seconds.
[0150] As shown in FIGS. 10A-10P, the first microneedle configuration is much more efficient at cooling the wart and dermis in the simulation more evenly, deeply,HENK_100.100quickly. For example, by seven seconds (FIG. 10H), tissue at a depth along the entire length of the microneedles 240 reaches the desired temperature of between about - 20°C and about -40°C for a benign (non-cancerous) tissue, between about -40°C and about -60°C for a malignant (cancerous) tissue, and between about -60°C and about - 100°C or colder, in some embodiments. By five seconds (FIG. 10F), the entirety of wart box 1410 and a conical shape under wart box 1410 reaches the desired thermal ablation temperature of about -40°C, as discussed above.
[0151] The thermal ablation device modeled in FIGS. 11A-11P has a second microneedle configuration. The second configuration includes three microneedles 240 having DT 0.1 mm, Ls 1.0 mm, and LB of 0.2 mm. FIGS. 11A-11P show the simulation from zero to fifteen seconds. Specifically, FIG. 11A shows the simulation at zero seconds, FIG. 11B shows the simulation at one second, FIG. 11C shows the simulation at two seconds, FIG. 11D shows the simulation at three seconds, FIG. HE shows the simulation at four seconds, FIG. HF shows the simulation at five seconds, FIG. 11G shows the simulation at six seconds, FIG. 11H shows the simulation at seven seconds, FIG. HI shows the simulation at eight seconds, FIG.11 J shows the simulation at nine seconds, FIG. HK shows the simulation at ten seconds, FIG. HL shows the simulation at eleven seconds, FIG. HM shows the simulation at twelve seconds, FIG. UN shows the simulation at thirteen seconds, FIG. HO shows the simulation at fourteen seconds, FIG. HP shows the simulation at fifteen seconds.
[0152] As shown in FIGS. 11A-11P, much like with the first configuration in FIGS 10A-10P, the second configuration of microneedles 240 is much more efficient at cooling the wart and dermis in the simulation more evenly, deeply, quickly than the cryospray simulation. For example, by six seconds (FIG. HG), tissue at a depth along the entire length of the microneedles 240 reaches the desired temperature of between about -20°C and about -40°C for a benign (non-cancerous) tissue, between about -40°C and about -60°C for a malignant (cancerous) tissue, and between about - 60°C and about -100°C or colder, in some embodiments.. By fifteen seconds (FIG. HP), the entirety of wart box 1410 and an even deeper conical shape under wart box 1410 reaches the desired thermal ablation temperature. It is important to target this location because it is the most common location of the root of the wart which needs to be treated in order to permanently treat the wart.HENK_100.100
[0153] The thermal ablation device modeled in FIGS. 12A-12P has a third microneedle configuration. The third configuration includes three microneedles 240 having DT 0.05 mm, Ls 0.6 mm, and LB of 0.1 mm. FIGS. 12A-12P show the simulation from zero to fifteen seconds. Specifically, FIG. 12A shows the simulation at zero seconds, FIG. 12B shows the simulation at one second, FIG. 12C shows the simulation at two seconds, FIG. 12D shows the simulation at three seconds, FIG. 12E shows the simulation at four seconds, FIG. 12F shows the simulation at five seconds, FIG. 12G shows the simulation at six seconds, FIG. 12H shows the simulation at seven seconds, FIG. 121 shows the simulation at eight seconds, FIG.12J shows the simulation at nine seconds, FIG. 12K shows the simulation at ten seconds, FIG. 12L shows the simulation at eleven seconds, FIG. 12M shows the simulation at twelve seconds, FIG. 12N shows the simulation at thirteen seconds, FIG. 120 shows the simulation at fourteen seconds, FIG. 12P shows the simulation at fifteen seconds.
[0154] As shown in FIGS. 12A-12P, as with the first and second microneedle configurations, the third configuration of microneedles 240 is more efficient at cooling the wart and dermis in the simulation more evenly, deeply, quickly than the cryospray simulation. For example, by eight seconds (FIG. 121), tissue at a depth along the entire length of the microneedles 240 reaches the desired temperature of between about -20°C and about -40°C for a benign (non-cancerous) tissue, between about -40°C and about -60°C for a malignant (cancerous) tissue, and between about - 60°C and about -100°C or colder, in some embodiments... By fifteen seconds (FIG.12P), the lower comers of wart box 1410 have not reached the ablation temperature and the dermis below the central microneedle is not white throughout its depth as it was for the first and second configuration simulations by this time. The third configuration of microneedles 240 has smaller spacing of microneedles 240 than the first two configurations. Therefore, a narrower section of wart and dermis is cooled to the desired thermal ablation temperature. This configuration is beneficial for warts and lesions that have more narrow roots or who are located near nerves or sensitive organs where a more narrow, conservative ablation approach is required.
[0155] The thermal ablation device modeled in FIGS. 13A-13P has a fourth microneedle configuration. The fourth configuration includes three microneedles 240 having DT 0.05 mm, Ls 1.0 mm, and LB of 0.1 mm. FIGS. 13A-13P show the simulation from zero to fifteen seconds. Specifically, FIG. 13A shows the simulationHENK_100.100at zero seconds, FIG. 13B shows the simulation at one second, FIG. 13C shows the simulation at two seconds, FIG. 13D shows the simulation at three seconds, FIG. 13E shows the simulation at four seconds, FIG. 13F shows the simulation at five seconds, FIG. 13G shows the simulation at six seconds, FIG. 13H shows the simulation at seven seconds, FIG. 131 shows the simulation at eight seconds, FIG.13J shows the simulation at nine seconds, FIG. 13K shows the simulation at ten seconds, FIG. 13L shows the simulation at eleven seconds, FIG. 13M shows the simulation at twelve seconds, FIG. 13N shows the simulation at thirteen seconds, FIG. 130 shows the simulation at fourteen seconds, FIG. 13P shows the simulation at fifteen seconds.
[0156] As shown in FIGS. 13A-13P, as with the first, second, and third microneedle configurations, the fourth configuration of microneedles 240 is more efficient at cooling the wart and dermis in the simulation than the cryospray simulation. For example, by nine seconds (FIG. 13J), tissue at a depth along the entire length of the microneedles 240 reaches the desired temperature of between about -20°C and about -40°C for a benign (non-cancerous) tissue, between about -40°C and about -60°C for a malignant (cancerous) tissue, and between about -60°C and about -100°C or colder, in some embodiments. By fifteen seconds (FIG. 13P), the lower corners of wart box 1410 have not reached the ablation temperature and the dermis below the central microneedle is not white throughout its depth. This configuration is beneficial in situation where a precise temperature depth is required in situations where the wart is situated proximate to sensitive tissues, nerves, or organs.
[0157] The primary COMSOL input geometry provided in FIG. 14 illustrates points 1450, 1460, 1470, and 1470, which are point-temperature measurement locations used to summarize the simulation temperature results from FIGS. 9-13 and display them in FIGS. 15-19. Points 1450, 1460, 1470, and 1470 are taken at points [-0.5mm, 0mm], [-0.5mm, -0.5mm], [-0.5mm, -1mm], [-0.5mm, -1.5mm], respectively within dermis 1420, and correspond to legend symbols [+, ■, *, O].
[0158] FIG. 14 is a graph illustrating the simulation parameters for FIGS. 9-13.
[0159] FIG. 15 is a graph summarizing the temperature results of the simulation from FIGS. 9A-9P that simulate treating a cutaneous wart with existing thermal ablation devices. FIG. 16 is a graph summarizing the temperature results of the simulation from FIGS. 10A-10P that simulate treating a cutaneous wart using one configurationHENK_100.100the disclosed microneedle thermal ablation device over time. FIG. 17 is a graph summarizing the temperature results of the simulation from FIGS. 11A-11P that simulate treating a cutaneous wart using a second configuration the disclosed microneedle thermal ablation device over time. FIG. 18 is a graph summarizing the temperature results of the simulation from FIGS. 12A-12P that simulate treating a cutaneous wart using a third configuration the disclosed microneedle thermal ablation device over time. FIG. 19 is a graph summarizing the temperature results of the simulation from FIGS. 13A-13P that simulate treating a cutaneous wart using a fourth configuration the disclosed microneedle thermal ablation device over time.
[0160] As is evident from the trend lines the graphs shown in FIGS. 15-19, the temperature of tissue in the prior are device simulation summarized in FIG. 15 falls much more slowly over time than do the temperatures of the presently disclosed thermal ablation devices summarized in FIGS. 16-19.
[0161] Overall FIGS. 10-13 and FIGS. 16-19 illustrate the intense degree of customization the thermal ablation devices of the present disclosure provide medical practitioners over existing devices. Small adjustments, in the degree of fractions of a millimeter, in the dimensions of the microneedles 240 result in marked changes to the ablation boundary and profile. This degree of locality and control provides users with powerful abilities to manipulate the thermal ablation boundary and profile to best suit the target tissue at hand. The presently disclosed devices and methods therefore provide increased, safety, efficacy, and control over existing thermal ablation devices and methods.
[0162] Thermal ablation devices and methods of the present disclosure provide significant improvements over the prior art. By penetrating the target tissue volume of interest with highly conductive material rather than waiting for heat to transfer in small -valued tissue, the time taken for ablation of tissue decreases. By penetrating the target tissue volume of interest with spikes of different shapes, the surface area of heat to flow through increases, and thus directionally increases ablative efficiency and control. Therefore, by exerting efficiencies multiple orders of magnitude greater than current thermal ablation techniques, presently disclosed devices and methods provide markedly enhanced controlled tumor destruction and precision medicine. The thermal ablation devices and methods of the present disclosure provide precise, localized heating or cooling at the microneedles, reducing collateral tissue damage compared,HENK_100.100procedure time, and the necessity of repeat treatments as compared to traditional thermal ablation methods.
[0163] The embodiments and examples set forth herein were presented to best explain the present invention and its practical applications, and to thereby enable those of ordinary skill in the art to make and use the invention. However, those of ordinary skill in the art will recognize that the foregoing description and examples have been presented for the purpose of illustration and example. The description as set forth is not intended to be exhaustive or to limit the invention to the precise form disclosed. Many modifications and variations are possible, in light of the teachings herein above.
Claims
CLAIMSWhat is claimed is:
1. A thermal ablation device comprising:a central body having a first wall and a contact wall; anda plurality of microneedles, each microneedle having a base coupled to the contact wall and a length extending from the base ending in a tip opposite the base.
2. The device of claim 1, wherein the plurality of microneedles forms a planar array on the contact wall.
3. The device of claim 2, wherein the planar array is a two-dimensional shape from the group of shapes consisting of a circle, an ellipse, a triangle, a rectangle, or a polygon.
4. The device of claim 1, wherein the contact wall presents a three-dimensional surface from a group of three-dimensional shapes consisting of a sphere, a hemisphere, a cone, a pyramid, a cylinder, a polygonal prism, or a combination thereof.
5. The device of claim 1, further comprising a thermal reservoir thermally coupled to the central body.
6. The device of claim 1, wherein the central body is an inflatable balloon wherein the contact surface is formed by an outer surface of the balloon.
7. The device of claim 1, wherein the thermal ablation device comprises a cooling device from a group of cooling devices consisting of a cryogenic device, or a thermoelectric effect cooling device.
8. The device of claim 1, wherein the thermal ablation device comprises a heating device from a group of heating devices consisting of a resistive, an induction heating, a radiofrequency ablation, a microwave ablation, a laser ablation, or a thermoelectric effect heating device.
9. The device of claim 1 , wherein the microneedle length varies across the array to collectively form a curvilinear needle tip array.
10. The device of claim 9, wherein the needle tip array forms a hemispherical surface curve.
11. The device of claim 9, wherein the needle tip array forms a cylindrical surface curve.
12. The device of claim 9, wherein the needle tip array forms a semi -lenticular surface curve.
13. The device of claim 9, herein the plurality of microneedles coupled to the contact surface are movable between a first (retracted) position and a second (extended) position.
14. The device of claim 9, wherein the balloon is coupled to a catheter and configured to be deployed from a distal end of a catheter outer sheath.
15. Athermal ablation device comprising:a tip havinga central body with a first wall configured to contact a thermal source and a contact wall positioned proximate to a lesion;a plurality of microneedles, each microneedle having a base coupled to the contact wall and a length extending from the base ending in a tip opposite the base; andan attachment means configured to removably couple the central body to a thermal delivery device.
16. A method of using a thermal ablation device comprising:obtaining a thermal ablation device having a central body coupled to a plurality of microneedles;coupling a thermal delivery device configured to deliver a thermal load to the thermal ablation device;contacting a target tissue surface with the thermal ablation device wherein the microneedles penetrate through the tissue surface into the target tissue; activating the thermal delivery device causing a thermal load to be delivered to the central body for a time period;deactivating the thermal delivery device when the time period is complete; and removing the thermal ablation device from the target tissue surface.
17. The method of claim 16, wherein the target tissue is a common skin wart, a genital wart, a perianal wart, a seborrheic keratosis, a skin tag, a cherry angioma, a solar lentigo, a lentigo maligna, an actinic keratosis, a uterine fibroid, an arteriovenous malformation, a squamous cell carcinoma, a basal cell carcinoma, or a melanoma.
18. The method of claim 16, wherein the thermal ablation device comprises a three- dimensional microneedle array forming a deep tissue conductive apparatus.
19. The method of claim 16, wherein the microneedles are curvilinear.
20. The method of claim 16, further comprising a calculating step wherein the time period is calculated to produce an ablation boundary having a depth, shape, and volume to include the target tissue and exclude a non-target tissue bordering the target tissue.
